TY  - JOUR
AU  - Pozzilli, Paolo
AU  - Bosi, Emanuele
AU  - Cirkel, Deborah
AU  - Harris, Julia
AU  - Leech, Nicola
AU  - Tinahones, Francisco J
AU  - Vantyghem, Marie-Christine
AU  - Vlasakakis, Georgios
AU  - Ziegler, Anette-Gabriele
AU  - Janmohamed, Salim
PY  - 2020
DO  - 10.1210/clinem/dgaa149
UR  - http://hdl.handle.net/10668/15294
T2  - The Journal of clinical endocrinology and metabolism
AB  - GLP-1 receptor agonists are an established therapy in patients with type 2 diabetes; however, their role in type 1 diabetes remains to be determined. Determine efficacy and safety of once-weekly albiglutide 30 mg (up-titration to 50 mg at week 6)...
LA  - en
PB  - Oxford University Press
KW  - GLP-1 receptor agonist
KW  - albiglutide
KW  - insulin
KW  - type 1 diabetes mellitus
KW  - Adolescent
KW  - Adult
KW  - Biomarkers
KW  - Blood Glucose
KW  - Diabetes Mellitus, Type 1
KW  - Female
KW  - Follow-Up Studies
KW  - Glucagon-Like Peptide 1
KW  - Humans
KW  - Incretins
KW  - Male
KW  - Prognosis
KW  - Young Adult
TI  - Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes.
TY  - research article
VL  - 105
ER  -